1. FDA . Kefauver-Harris amendments Revolutionized drug development, 2012. Available: https://www.fda.gov/consumers/consumer-updates/kefauver-harris-amendments-revolutionized-drug-development
2. Risk evaluation and mitigation strategies (REMSs): are they improving drug safety? A critical review of REMSs requiring elements to Assure safe use (ETASU);Boudes;Drugs R D,2017
3. FDA . Approved risk evaluation and mitigations strategies (REMS). drug databases, 2019. Available: https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm
4. Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolate
5. What is the teratogenic risk of mycophenolate?;Kylat;J Pediatr Genet,2017